IP Library Granted Patent US 8,546,340
Granted Patent B2
US 8,546,340 · App. 13/141,392 · Granted Oct 1, 2013

Soothing pharmaceutical or cosmetic composition comprising a peptide that activates HMG-CoA reductase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,546,340
App. No.
13/141,392
Granted
Oct 1, 2013
Kind
B2
Abstract

A soothing cosmetic or pharmaceutical composition that includes at least one peptide that activates human HMG-CoA reductase general formula (I): R 1 -(AA) n -X 1 -Gly-Glu-Leu-Ser-X 2 -X 3 -(AA p -R 2 in a physiologically suitable medium is disclosed. The invention further applies to a cosmetic treatment method intended to combat skin irritations. Additionally, methods of treating skin irritations with such a composition are described.

Claims (17)

1. A cosmetic treatment method to soothe sensitive skin, the method comprising:

topically applying, to skin to be treated, a composition comprising an effective quantity of a peptide in a cosmetically suitable medium, wherein the peptide is derived from human HMG-CoA reductase, and is:

Ala-Gly-Glu-Leu-Ser, or

(SEQ ID NO: 4)

Ala-Gly-Glu-Leu-Ser-NH 2

(SEQ ID NO: 5).

2. The method of claim 1 , wherein the peptide corresponds to the SEQ ID NO: 4.

3. The method of claim 1 , wherein the peptide corresponds to the SEQ ID NO: 5.

4. The method of claim 1 , wherein the peptide is present at a concentration of between 0.0005 and 500 ppm.

5. The method of claim 4 , wherein the peptide is present at a concentration of between 0.01 and 5 ppm.

6. The method of claim 1 , wherein the peptide is solubilized in one or more physiologically acceptable solvents selected from the group consisting of water, glycerol, ethanol, propylene glycol, butylene glycol, dipropylene glycol, ethoxylated diethylene glycol or propoxylated diethylene glycol, cyclic polyols, white petroleum jelly, vegetable oil and combinations thereof.

7. The method of claim 1 , wherein the composition contains at least one other active principle with an irritant side effect selected from the group consisting of alpha-hydroxy-acids, ss-hydroxy-acids, a-keto-acids, vitamin C, retinoids, minoxidil, lithium salts, para-phenylenediamine (p-PDA), N-phenyl p-PDA, toluene 2,5-diamine sulfate, meta-phenylenediamine, toluene 3,4-diamine, ortho-phenylenediamine, hydroquinone; and the step of topically applying, to skin to be treated, is to reduce or eliminate the irritant side effect of said at least one other active principle.

8. The method of claim 1 , wherein the step of topically applying to skin to be treated further treats cutaneous inflammation.

9. The method according to claim 8 , wherein the cutaneous inflammation is due to ultraviolet radiation, pruritus, urticaria, insect bites, allergies or alopecia in its inflammatory phases.

10. A cosmetic treatment method to soothe sensitive skin, the method comprising:

topically applying, to skin to be treated:

a composition comprising an effective quantity of a peptide in a cosmetically suitable medium, wherein the peptide is (SEQ ID NO: 4) Ala-Gly-Glu-Leu-Ser or (SEQ ID NO: 5) Ala-Gly-Glu-Leu-Ser-NH 2 .

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CONVERSION Recorded Jan 30, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041556/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2011
From: DAL FARRA, CLAUDE; DOMLOGE, NOUHA; BOTTO, JEAN-MARIE
To: ISP INVESTMENTS INC.
Reel/Frame 026726/0844 →